Tumori maligni negli Stati Uniti fascia di età 0-54 anni
Tumori maligni negli Stati Uniti fascia di età 0-54 anni

 

TURBO CANCER LITERATURE (15 papers):

 
  • (2024 Apr, Zhang and El-Deiry) – SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells

  • (2024 Apr, Rubio-Casillas et al) – Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?

  • (2024 Apr, Gibo et al) – Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

  • (2023 Dec, Angues et al) – SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis

  • (2023 Nov, Patrick Chambers) – The CD147 Epitope on SARS CoV2 and the Spike in Cancer, Autoimmunity and Organ Fibrosis

  • (2023 Oct, Speicher et al) – DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.

  • (2023 Sep, McKernan et al) – Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose

  • (2023 May, Uversky, Redwan, Makis, Rubio-Casillas) – IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

  • (2023 May, Eens et al) – B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

  • (2023 Apr, Halma, Rose, Lawrie) – The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review

  • (2023 March, Guetzkow et al) – National Academies Committee on Review of Relevant Literature Regarding Adverse Events Associated with Vaccines

  • (2022 May, Jiang et al) – SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (Retracted)

  • (2022 Apr, Seneff et al) – Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs

  • (2022 Feb, Alden et al) – Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

  • (2020 Oct, Singh) – S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study

 

TURBO CANCER CASES (11 papers):

 
  • (2024 Apr, Abdurrahman et al) – Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine

  • (2024 Apr, Ueda et al) – Fetal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case

  • (2024 Apr, Gentilini et al) – A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature

  • (2023 Sep, Kyriakopoulos et al) – Bell’s palsy or an aggressive infiltrating basaloid carcinoma post-mRNA vaccination for COVID-19? A case report and review of the literature

  • (2023 Apr, Tachita et al) – Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination

  • (2023 Jan, Cavanna et al) – Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature

  • (2022 Sep, Revenga-Porcel et al) – 76M lymphoma after 3rd Moderna mRNA

  • (2022 Aug, Sekizawa et al) – 80F lymphoma after 2nd Pfizer mRNA

  • (2022 Jun, Zamfir et al) – 58F 2nd Pfizer, 53M 2nd Pfizer both lymphoma

  • (2022 Apr, Mitsui et al) – 67M 2nd Pfizer, 80F 2nd Pfizer both lymphoma

  • (2021 Nov, Goldman et al) – 66M lymphoma progression after 3rd Pfizer mRNA

 

Fonte: DR. WILLIAM MAKIS MD sul suo Substack.

 


Le opinioni espresse in questo articolo sono dell’autore e non riflettono necessariamente quelle del responsabile di questo blog. I contributi pubblicati su questo blog, ritenuti degni di rilievo, hanno il solo ed unico scopo di far riflettere, di alimentare il dibattito e di approfondire la realtà. Qualora gli autori degli articoli che vengono qui rilanciati non avessero piacere della pubblicazione, non hanno che da segnalarmelo. Gli articoli verranno immediatamente cancellati.


 

Sostieni il Blog di Sabino Paciolla

 






 

 

Facebook Comments